Observational study on brain calcification characteristics
Official title: A Registered Cohort Study on Brain Calcification
Run by First Affiliated Hospital of Fujian Medical University · NCT04010201 · Data updated 2026-11-12
This study is trying to learn more about brain calcification by looking at patients with calcium deposits in their brains, their family members, and healthy individuals to see how it affects health over time.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | First Affiliated Hospital of Fujian Medical University Academic / other |
| Locations | 1 site (Fuzhou, Fujian) |
| Status | Recruiting |
| Started | August 25, 2019 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2079 |
| Registry record updated | September 23, 2019 |
| Trial ID | NCT04010201 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with brain calcium deposits as identified by CT scans, their relatives, and unrelated healthy controls.
✕Probably not a fit
Patients with brain calcification due to specific secondary factors such as infections, poisoning, or trauma may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to establish a cohort of patients with brain calcification to investigate their clinical and genetic characteristics. It will include patients with brain calcium deposits identified through CT scans, as well as their relatives and unrelated healthy controls. The study will follow these participants over time to gather data on the natural history of brain calcification and its potential associations with various disorders. By understanding these factors, the study seeks to shed light on the implications of brain calcification in different populations.
Why it matters
Potential benefit: If successful, this study could enhance understanding of brain calcification and its implications for various neurological conditions, potentially leading to improved patient management.
How similar studies have gone: While there may be studies on brain calcification, this cohort approach focusing on genetic and clinical characteristics is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with brain calcium deposit(s) based on examinations of CT scans * Patients with total calcification score(TCS) greater than the physiological threshold * Relatives of brain calcification patients. * Unrelated healthy controls * Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process Exclusion Criteria: * Brain calcification caused by specific secondary factors such as infection, poisoning, and trauma * Participants declining or unable to comply with trial procedures and visit schedule
Where it's running
-
Department of Neurology, First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, China Recruiting
Study contacts
- Study coordinator: Yi Lin, PhD
- Email: linyi7811@163.com
- Phone: 86-0591-87982772
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Delayed Ga-68 DOTATATE PET/MR for Detecting Liver Metastases in GEP-NETs
This study tests whether a delayed Ga-68 DOTATATE PET/MR scan can better detect liver metastases in gastroenteropancreatic neuroendocrine tumors compared with the standard Ga-68 DOTATATE PET/CT.
-
Preventive Narrative Exposure for PTSD After Cardiac Surgery in the ICU
In adults having cardiopulmonary bypass heart surgery, this trial tests whether an ICU-based narrative exposure intervention helps prevent posttraumatic stress symptoms compared with standard care.
-
A lifetime registry and imaging database for people with heart, kidney, and metabolic conditions
This project will see if creating a long-term clinical and imaging database for adults with heart, kidney, or metabolic conditions can improve prediction of outcomes and guide care.
-
Low-intensity focused ultrasound targeting the globus pallidus to improve movement in Huntington's disease
This trial tests whether different pulse frequencies of low-intensity focused ultrasound (LIFU) aimed at a deep brain target can safely reduce chorea and other motor symptoms in adults with Huntington's disease.
-
Using AI language models to help diagnose and recommend treatments for urologic conditions
This project will test whether three AI language models (ChatGPT, Gemini, DeepSeek) can accurately recognize urologic diseases and suggest diagnoses and treatments from archived hospital records of adult patients.
-
Sequential 225Ac-LNC1011 treatment for metastatic castration-resistant prostate cancer
We'll test whether different doses of a PSMA-targeted alpha therapy called 225Ac-LNC1011 are safe and can shrink tumors in men whose prostate cancer has spread and no longer responds to hormone therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.